vimarsana.com

இயக்குனர் மருத்துவ புற்றுநோயியல் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

OSE Immunotherapeutics and the FoRT Foundation Announce Initiation of a Phase 2 Clinical Trial Evaluating Tedopi in Combination with Opdivo (nivolumab) in Non-Small Cell Lung Cancer

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.